Variation within the serotonin (5-HT) 5-HT2C receptor system aligns with vulnerability to cocaine cue reactivity

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Anastasio, N C ^a   Liu, S ^b   Maili, L ^b   Swinford, Se ^a   Lane, S D ^b   Fox, R G ^a   Hamon, S C ^c   Nielsen, D A ^d   Cunningham, K A ^a   Moeller, F G ^e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Statistical and Genetic Consulting LLC   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attentional bias; Cocaine; Cue reactivity; Prefrontal cortex; Serotonin

Indexed keywords

1,2,3,4,8,9,10,10A OCTAHYDRO 7BH CYCLOPENTA[B][1,4]DIAZEPINO[6,7,1 HI]INDOLE; COCAINE; CYSTEINE; SERINE; SEROTONIN 2C RECEPTOR; 1,2,3,4,8,9,10,10A-OCTAHYDRO-7BH-CYCLOPENTA(B)(1,4)DIAZEPINO(6,7,1HJ)INDOLE; AZEPINE DERIVATIVE; INDOLE DERIVATIVE; SEROTONIN 2 AGONIST;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTIONAL BIAS; COCAINE DEPENDENCE; CODON; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; FEMALE; FUNCTIONAL STATUS; GENE; GENETIC VARIABILITY; HTR2C GENE; HUMAN; MALE; NONHUMAN; OBSERVATIONAL STUDY; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; RELAPSE; RODENT; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STROOP TEST; ANIMAL TISSUE; APPETITE; ASSOCIATION; GENETIC CODE; REINFORCEMENT; RESPONSE TIME; VENTROMEDIAL PREFRONTAL CORTEX; ANIMAL; ATTENTION; DRUG EFFECTS; GENETICS; INDIVIDUALITY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADULT; ANIMALS; APPETITIVE BEHAVIOR; ATTENTION; AZEPINES; COCAINE; COCAINE-RELATED DISORDERS; CUES; FEMALE; HUMANS; INDIVIDUALITY; INDOLES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN 5-HT2 RECEPTOR AGONISTS; STROOP TEST;

EID: 84902577024     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.131     Document Type: Article

References (69)

1. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010; 35: 217-238.
2. Janes AC, Pizzagalli DA, Richardt S, deB FB, Chuzi S, Pachas G et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry 2010; 67: 722-729.
3. Back SE, Hartwell K, DeSantis SM, Saladin M, Rae-Clark AL, Price KL et al. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend 2010; 106: 21-27.
4. Rohsenow DJ, Niaura RS, Childress AR, Abrams DB, Monti PM. Cue reactivity in addictive behaviors: theoretical and treatment implications. Int J Addict 1990; 25 (7A-8A): 957-993.
5. Carter BL, Tiffany ST. Cue-reactivity and the future of addiction research. Addiction 1999; 94: 349-351.
6. Field M, Cox WM. Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend 2008; 97(1-2): 1-20.
7. Modesto-Lowe V, Kranzler HR. Using cue reactivity to evaluate medications for treatment of cocaine dependence: a critical review. Addiction 1999; 94: 1639-1651.
8. Mahler SV, de Wit H. Cue-reactors: individual differences in cue-induced craving after food or smoking abstinence. PLoS One 2010; 5: e15475.
9. Flagel SB, Robinson TE, Clark JJ, Clinton SM, Watson SJ, Seeman P et al. An animal model of genetic vulnerability to behavioral disinhibition and responsiveness to reward-related cues: implications for addiction. Neuropsychopharmacology 2010; 35: 388-400.
10. Tomie A, Grimes KL, Pohorecky LA. Behavioral characteristics and neurobiological substrates shared by Pavlovian sign-tracking and drug abuse. Brain Res Rev 2008; 58: 121-135.
11. Hendershot CS, Witkiewitz K, George WH, Marlatt GA. Relapse prevention for addictive behaviors. Subst Abuse Treat Prev Policy 2011; 6: 17.
12. Prisciandaro JJ, Myrick H, Henderson S, Rae-Clark AL, Brady KT. Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Drug Alcohol Depend 2013; 131(1-2): 44-49.
13. Goldstein RZ, Tomasi D, Alia-Klein N, Honorio CJ, Maloney T, Woicik PA et al. Dopaminergic response to drug words in cocaine addiction. J Neurosci 2009; 29, 6001-6006.
14. Lidov HGW, Grzanna R, Molliver ME. The serotonin innervation of the cerebral cortex in the rat: An immunohistochemical analysis. Neuroscience 1980; 5: 207-227.
15. Vertes RP, Linley SB. Efferent and afferent connections of the dorsal and median raphe nuclei in the rat. In: Monti JM, Pandi-Perumal SR, Jacobs BL, Nutt DJ (eds). Serotonin and Sleep: Molecular, Functional and Clinical Aspects. Birkhäuser Verlag: Basel, Switzerland, pp. 69-102, 2008.
16. Cunningham KA, Anastasio NC. Serotonin at the nexus of impulsivity and cue ceactivity in cocaine addiction. Neuropharmacology 2013; 76(Pt B): 460-478.
17. Pompeiano M, Palacios JM, Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: Comparison between 5-HT2A and 5-HT2C receptors. Mol Brain Res 1994; 23: 163-178.
18. Uylings HB, Groenewegen HJ, Kolb B. Do rats have a prefrontal cortex? Behav Brain Res 2003; 146(1-2): 3-17.
19. Goldstein RZ, Tomasi D, Rajaram S, Cottone LA, Zhang L, Maloney T et al. Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 2007; 144: 1153-1159.
20. Baeg EH, Jackson ME, Jedema HP, Bradberry CW. Orbitofrontal and anterior cingulate cortex neurons selectively process cocaine-associated environmental cues in the rhesus monkey. J Neurosci 2009; 29: 11619-11627.
21. Lu H, Chefer S, Kurup PK, Guillem K, Vaupel DB, Ross TJ et al. fMRI response in the medial prefrontal cortex predicts cocaine but not sucrose self-administration history. Neuroimage 2012; 62: 1857-1866.
22. Pentkowski NS, Duke FD, Weber SM, Pockros LA, Teer AP, Hamilton EC et al. Stimulation of medial prefrontal cortex serotonin 2C 5-HT2C receptors attenuates cocaine-seeking behavior. Neuropsychopharmacology 2010; 35: 2037-2048.
23. Cunningham KA, Anastasio NC, Fox RG, Stutz SJ, Bubar MJ, Swinford SE et al. Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5- HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction. ACS Chem Neurosci 2013; 4: 110-121.
24. Neisewander JL, Acosta JI. Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol 2007; 18: 791-800.
25. Fletcher PJ, Grottick AJ, Higgins GA. Differential effects of the 5-HT2A receptor antagonist M100,907 and the 5-HT2C receptor antagonist SB242,084 on cocaineinduced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 2002; 27: 576-586.
26. Grottick AJ, Fletcher PJ, Higgins GA. Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 2000; 295: 1183-1191.
27. Cunningham KA, Fox RG, Anastasio NC, Bubar MJ, Stutz SJ, Moeller FG et al. Selective serotonin 5-HT2C receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs sucrose-associated cues. Neuropharmacology 2011; 61: 513-523.
28. Manvich DF, Kimmel HL, Cooper DA, Howell LL. The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys. J Pharmacol Exp Ther 2012; 342: 761-769.
29. Pelloux Y, Dilleen R, Economidou D, Theobald D, Everitt BJ. Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats. Neuropsychopharmacology 2012; 37: 2505-2514.
30. Manvich DF, Kimmel HL, Howell LL. Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 2012; 341: 424-434.
31. Anastasio NC, Stutz SJ, Fox RG, Sears RM, Emeson RB, DiLeone RJ et al. Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence. Neuropsychopharmacology 2014; 39: 370-382.
32. Lappalainen J, Zhang L, Dean M, Oz M, Ozaki N, Yu DH et al. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics 1995; 27: 274-279.
33. Piva F, Giulietti M, Baldelli L, Nardi B, Bellantuono C, Armeni T et al. Bioinformatic analyses to select phenotype affecting polymorphisms in HTR2C gene. Hum Psychopharmacol 2011; 26: 365-372.
34. Okada M, Northup JK, Ozaki N, Russell JT, Linnoila M, Goldman D. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution. Mol Psychiatry 2004; 9: 55-64.
35. Walstab J, Steinhagen F, BRUSS M, Gothert M, Bonisch H. Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization. Pharmacol Rep 2011; 63: 45-53.
36. Brasch-Andersen C, Moller MU, Christiansen L, Thinggaard M, Otto M, Brosen K et al. A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C). Eur J Clin Pharmacol 2011; 67: 1131-1137.
37. Kuhn KU, Joe AY, Meyer K, Reichmann K, Maier W, Rao ML et al. Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor. Pharmacopsychiatry 2004; 37: 286-291.
38. Quested DJ, Whale R, Sharpley AL, McGavin CL, Crossland N, Harrison PJ et al. Allelic variation in the 5-HT2C receptor (HTR2C) and functional responses to the 5- HT2C receptor agonist, m-chlorophenylpiperazine. Psychopharmacology (Berl) 1999; 144: 306-307.
39. Saltzman AG, Morse B, Whitman MM, Ivanshchenko Y, Jaye M, Felder S. Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem Biophys Res Commun 1991; 181: 1469-1478.
40. Xie EZ, Zhu LY, Zhao LY, Chang LS. The human serotonin 5-HT2c receptor: Complete cDNA, genomic structure, and alternatively spliced variant. Genomics 1996; 35: 551-561.
41. First, MB Spitzer, RL Gibbon, M Williams, JB. Structured Clinical Interview for DSMIV Axis I Disorders-Patient Edition. Biometrics Research Department, New York State Psychiatric Institute: New York, NY, USA, 1996.
42. Hester R, Dixon V, Garavan H. A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task. Drug Alcohol Depend 2006; 81: 251-257.
43. Liu S, Lane SD, Schmitz JM, Green CE, Cunningham KA, Moeller FG. Increased intra-individual reaction time variability in cocaine-dependent subjects: role of cocaine-related cues. Addict Behav 2012; 37: 193-197.
44. Liu S, Lane SD, Schmitz JM, Waters AJ, Cunningham KA, Moeller FG. Relationship between attentional bias to cocaine-related stimuli and impulsivity in cocainedependent subjects. Am J Drug Alcohol Abuse 2011; 37: 117-122.
45. Field M, Munafo MR, Franken IH. A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychol Bull 2009; 135: 589-607.
46. Cox WM, Fadardi JS, Pothos EM. The addiction-stroop test: Theoretical considerations and procedural recommendations. Psychol Bull 2006; 132: 443-476.
47. Kosten TR, Wu G, Huang W, Harding MJ, Hamon SC, Lappalainen J et al. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase. Biol Psychiatry 2013; 73: 219-224.
48. Kosten TR, Domingo CB, Hamon SC, Nielsen DA. DBH gene as predictor of response in a cocaine vaccine clinical trial. Neurosci Lett 2013; 541: 29-33.
49. Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA. Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaineseeking behavior in a rat self-administration model. Behav Neurosci 2009; 123: 382-396.
50. Anastasio NC, Lanfranco MF, Bubar MJ, Seitz PK, Stutz SJ, McGinnis AG et al. Serotonin 5-HT(2C) receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex. J Neurochem 2010; 113: 1504-1515.
51. Liu S, Bubar MJ, Lanfranco MF, Hillman GR, Cunningham KA. Serotonin(2C) receptor localization in GABA neurons of the rat medial prefrontal cortex: Implications for understanding the neurobiology of addiction. Neuroscience 2007; 146: 1667-1688.
52. Waters AJ, Marhe R, Franken IH. Attentional bias to drug cues is elevated before and during temptations to use heroin and cocaine. Psychopharmacology (Berl) 2012; 219: 909-921.
53. Moeller SJ, Parvaz MA, Shumay E, Beebe-Wang N, Konova AB, Alia-Klein N et al. Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence. J Neurosci 2013; 33, 10027-10036.
54. Smelson D, Yu L, Buyske S, Gonzalez G, Tischfield J, Deutsch CK et al. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cuereactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. Am J Addict 2012; 21: 411-415.
55. Meyer PJ, Lovic V, Saunders BT, Yager LM, Flagel SB, Morrow JD et al. Quantifying individual variation in the propensity to attribute incentive salience to reward cues. PLoS One 2012; 7: e38987.
56. Brummett BH, Kuhn CM, Boyle SH, Babyak MA, Siegler IC, Williams RB. Cortisol responses to emotional stress in men: association with a functional polymorphism in the 5HTR2C gene. Biol Psychol 2012; 89: 94-98.
57. Mickey BJ, Sanford BJ, Love TM, Shen PH, Hodgkinson CA, Stohler CS et al. Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans. J Neurosci 2012; 32: 9344-9350.
58. Fentress HM, Grinde E, Mazurkiewicz JE, Backstrom JR, Herrick-Davis K, Sanders- Bush E. Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms. Pharmacogenomics J 2005; 5: 244-254.
59. Drago A, Serretti A. Focus on HTR2C: A possible suggestion for genetic studies of complex disorders. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 601-637.
60. Sanders-Bush E, Fentress H, Hazelwood L. Serotonin 5-HT2 receptors: Molecular and genomic diversity. Mol Interv 2003; 3: 319-330.
61. Handelsman L, Kahn RS, Sturiano C, Rinaldi PJ, Gabriel S, Schmeidler JP et al. Hostility is associated with a heightened prolactin response to metachlorophenylpiperazine in abstinent cocaine addicts. Psychiatry Res 1998; 80: 1-12.
62. Patkar AA, Mannelli P, Peindl K, Hill KP, Gopalakrishnan R, Berrettini WH. Relationship of disinhibition and aggression to blunted prolactin response to metachlorophenylpiperazine in cocaine-dependent patients. Psychopharmacology (Berl) 2006; 185: 123-132.
63. Filip M, Bubar MJ, Cunningham KA. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: Acute and chronic pharmacological analyses. J Pharmacol Exp Ther 2004; 310: 1246-1254.
64. Robinson TE, Flagel SB. Dissociating the predictive and incentive motivational properties of reward-related cues through the study of individual differences. Biol Psychiatry 2009; 65: 869-873.
65. Parsons LH, Koob GF, Weiss F. Extracellular serotonin is decreased in the nucleus accumbens during withdrawal from cocaine self-administration. Behav Brain Res 1995; 73(1-2): 225-228.
66. Rajagopal S, Ahn S, Rominger DH, Gowen-MacDonald W, Lam CM, Dewire SM et al. Quantifying ligand bias at seven-transmembrane receptors. Mol Pharmacol 2011; 80: 367-377.
67. Abe K, Fujimoto T, Akaishi T, Misawa M. Stimulation of basolateral amygdaloid serotonin 5-HT(2C) receptors promotes the induction of long-term potentiation in the dentate gyrus of anesthetized rats. Neurosci Lett 2009; 451: 65-68.
68. Potenza MN, Hong KI, Lacadie CM, Fulbright RK, Tuit KL, Sinha R. Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence. Am J Psychiatry 2012; 169: 406-414.
69. Munafo MR, Johnstone EC, Mackintosh B. Association of serotonin transporter genotype with selective processing of smoking-related stimuli in current smokers and ex-smokers. Nicotine Tob Res 2005; 7: 773-778.